Mengxiao Zhu

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy

Yubo Wang, Nong Yang, Yongchang Zhang et al. · Journal of Thoracic Oncology · 2020 · 100 citations

Cis-c797s Triple Mutations, Cetuximab Combination Therapy, Medicine +9

Down‐regulated desmocollin‐2 promotes cell aggressiveness through redistributing adherens junctions and activating beta‐catenin signalling in oesophageal squamous cell carcinoma

Wang‐Kai Fang, Lian‐Di Liao, Liyan Li et al. · The Journal of Pathology · 2013 · 65 citations

SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma

Ying Zhu, Mengxiao Zhu, Xiaodan Zhang et al. · Human Pathology · 2016 · 62 citations

Tumor Biology, Oncogenic Agent, Medicine +7

miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2

Haifeng Zhang, Kai Zhang, Lian‐Di Liao et al. · Carcinogenesis · 2013 · 56 citations · Full text

Serial ultra‐deep sequencing of circulating tumor DNA reveals the clonal evolution in non‐small cell lung cancer patients treated with anti‐PD1 immunotherapy

Li Li, Yubo Wang, Weiwei Shi et al. · Cancer Medicine · 2019 · 55 citations · Full text